Mitchell Stromberg

Associate

stromberg-mitchell-300
  • JD, cum laude, Harvard Law School, 2009; Intake Director, Harvard Legal Aid Bureau
  • BA, magna cum laude, Lewis & Clark College, 2005; Phi Beta Kappa

Qualifications

  • Massachusetts, 2009

Court Admissions

  • U.S. District Court for the District of Massachusetts
  • U.S. Court of Appeals for the First Circuit

Mitchell Stromberg

Associate

Mitchell Stromberg focuses his practice on white-collar criminal defense, government and internal investigations, and complex civil litigation. He has represented clients in criminal and civil matters involving FDA regulations, the False Claims Act, the Anti-Kickback Statute, the Foreign Corrupt Practices Act, products liability theories, state consumer protection statutes, and federal fraud and conspiracy statutes. He has considerable experience representing healthcare and life sciences companies, particularly medical device and pharmaceutical manufacturers.

Before joining Ropes & Gray in 2010, Mitchell taught legal advocacy to Harvard law students as a clinical fellow at the Harvard Legal Aid Bureau, where he had served as a board member and student advocate while in law school. He maintains an active pro bono practice in the area of housing law.

Experience

  • Representing a major medical device manufacturer in multi-year criminal and civil investigation involving off-label promotion allegations and novel theories of liability under the federal Food, Drug, and Cosmetic Act.
  • Member of team that successfully defended medical device manufacturer in federal criminal trial on felony charges of fraud, conspiracy, and off-label promotion.
  • Representing a multinational pharmaceutical company in Foreign Corrupt Practices Act investigations in China.
  • Successfully represented a medical device manufacturer in a qui tam action under the False Claims Act involving numerous theories of liability, securing dismissal of all claims with prejudice.
  • Representing a laboratory in connection with a civil and criminal investigation by United States Attorney’s Office and Center for Medicare and Medicaid Services.
Cookie Settings